CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Rivastigmine 250mg  | ≥99%

CSNpharm

Rivastigmine is a acetylcholinesterase inhibitor with IC50 value of 5.5 μM for cholinesterase, used for the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease.

More Information Supplier Page

Rivastigmine Tartrate 50mg  | ≥99%

CSNpharm

Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of ‎1.5 hours.

More Information Supplier Page

Rivastigmine Tartrate 10mg  | ≥99%

CSNpharm

Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of ‎1.5 hours.

More Information Supplier Page

Rivastigmine Tartrate 100mg  | ≥99%

CSNpharm

Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of ‎1.5 hours.

More Information Supplier Page

Rivastigmine Tartrate 250mg  | ≥99%

CSNpharm

Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of ‎1.5 hours.

More Information Supplier Page

RJR-2403 50mg  | ≥98%

CSNpharm

RJR-2403 is a neuronal nicotinic receptor agonist, showing high selectivity for the α4β2 subtype (Ki=26 nM) showing > 1,000 fold selectivity than α7 receptors (Ki= 36000 nM).

More Information Supplier Page

RJR-2403 10mg  | ≥98%

CSNpharm

RJR-2403 is a neuronal nicotinic receptor agonist, showing high selectivity for the α4β2 subtype (Ki=26 nM) showing > 1,000 fold selectivity than α7 receptors (Ki= 36000 nM).

More Information Supplier Page

RMI 10874 10mg  | ≥98%

CSNpharm

RMI 10874 is a tilorone analogue. Tilorone is a small-molecule, orally bioavailable antiviral agent. RMI 10874 completely abolishes lung colonization of an H-2 negative (GR9.B9) MCA-induced fibrosarcoma clone.

More Information Supplier Page

RMI 10874 1mg  | ≥98%

CSNpharm

RMI 10874 is a tilorone analogue. Tilorone is a small-molecule, orally bioavailable antiviral agent. RMI 10874 completely abolishes lung colonization of an H-2 negative (GR9.B9) MCA-induced fibrosarcoma clone.

More Information Supplier Page

RMI 10874 5mg  | ≥98%

CSNpharm

RMI 10874 is a tilorone analogue. Tilorone is a small-molecule, orally bioavailable antiviral agent. RMI 10874 completely abolishes lung colonization of an H-2 negative (GR9.B9) MCA-induced fibrosarcoma clone.

More Information Supplier Page

RN-1734 50mg  | ≥99%

CSNpharm

RN-1734 is selective antagonist of the TRPV4 channel, completely antagonizes 4αPDD-mediated activation of TRPV4 with comparable, low micromolar IC50 values for all three species (hTRPV4: IC50 = 2.3 μM, mTRPV4: IC50 = 5.9 μM, rTRPV4: IC50 = 3.2 μM).

More Information Supplier Page

RN-1734 5mg  | ≥99%

CSNpharm

RN-1734 is selective antagonist of the TRPV4 channel, completely antagonizes 4αPDD-mediated activation of TRPV4 with comparable, low micromolar IC50 values for all three species (hTRPV4: IC50 = 2.3 μM, mTRPV4: IC50 = 5.9 μM, rTRPV4: IC50 = 3.2 μM).

More Information Supplier Page

RN-1734 10mg  | ≥99%

CSNpharm

RN-1734 is selective antagonist of the TRPV4 channel, completely antagonizes 4αPDD-mediated activation of TRPV4 with comparable, low micromolar IC50 values for all three species (hTRPV4: IC50 = 2.3 μM, mTRPV4: IC50 = 5.9 μM, rTRPV4: IC50 = 3.2 μM).

More Information Supplier Page

RN-1734 25mg  | ≥99%

CSNpharm

RN-1734 is selective antagonist of the TRPV4 channel, completely antagonizes 4αPDD-mediated activation of TRPV4 with comparable, low micromolar IC50 values for all three species (hTRPV4: IC50 = 2.3 μM, mTRPV4: IC50 = 5.9 μM, rTRPV4: IC50 = 3.2 μM).

More Information Supplier Page

RN-1734 100mg  | ≥99%

CSNpharm

RN-1734 is selective antagonist of the TRPV4 channel, completely antagonizes 4αPDD-mediated activation of TRPV4 with comparable, low micromolar IC50 values for all three species (hTRPV4: IC50 = 2.3 μM, mTRPV4: IC50 = 5.9 μM, rTRPV4: IC50 = 3.2 μM).

More Information Supplier Page

Ro 20-1724 100mg  | ≥98%

CSNpharm

Ro20-1724 is a widely used inhibitor of cyclic nucleotide phosphodiesterase, selective for PDE4 (IC50 = 2.0 μM)

More Information Supplier Page

Ro 20-1724 250mg  | ≥98%

CSNpharm

Ro20-1724 is a widely used inhibitor of cyclic nucleotide phosphodiesterase, selective for PDE4 (IC50 = 2.0 μM)

More Information Supplier Page

Ro 31-8220 Mesylate 1mg  | ≥99%

CSNpharm

Ro 31-8220 mesylate is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively.

More Information Supplier Page

Ro 31-8220 Mesylate 50mg  | ≥99%

CSNpharm

Ro 31-8220 mesylate is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively.

More Information Supplier Page

Ro 31-8220 Mesylate 10mg  | ≥99%

CSNpharm

Ro 31-8220 mesylate is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively.

More Information Supplier Page

Ro 31-8220 Mesylate 5mg  | ≥99%

CSNpharm

Ro 31-8220 mesylate is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively.

More Information Supplier Page

Ro 48-8071 Fumarate 100mg  | ≥99%

CSNpharm

Ro 48-8071 Fumarate is an inhibitor of Oxidosqualene cyclase (OSC) with IC50 of 6.5 nM, also inhibits Ebola virus (EBOV) cell entry with IC50 of 1.74 μM and blocks cholesterol synthesis in HepG2 cells.

More Information Supplier Page

Ro 48-8071 Fumarate 25mg  | ≥99%

CSNpharm

Ro 48-8071 Fumarate is an inhibitor of Oxidosqualene cyclase (OSC) with IC50 of 6.5 nM, also inhibits Ebola virus (EBOV) cell entry with IC50 of 1.74 μM and blocks cholesterol synthesis in HepG2 cells.

More Information Supplier Page

Ro 48-8071 Fumarate 10mg  | ≥99%

CSNpharm

Ro 48-8071 Fumarate is an inhibitor of Oxidosqualene cyclase (OSC) with IC50 of 6.5 nM, also inhibits Ebola virus (EBOV) cell entry with IC50 of 1.74 μM and blocks cholesterol synthesis in HepG2 cells.

More Information Supplier Page